This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2016 Jun;20(3):322-41.

doi: 10.1007/s10157-015-1218-8.

Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014

Affiliations

Affiliations

¹ Kyorin University, Tokyo, Japan. arimuray@ks.kyorin-u.ac.jp.
² Kitano Hospital, Osaka, Japan.
³ Miyazaki University, Miyazaki, Japan.
⁴ Fujita Health University, Aichi, Japan.
⁵ Kyorin University, Tokyo, Japan.
⁶ Tsukuba University, Ibaraki, Japan.
⁷ Kyoto University, Kyoto, Japan.
⁸ Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
⁹ Tokyo Women's Medical University, Tokyo, Japan.
¹⁰ Kanazawa Medical Center, Ishikawa, Japan.
¹¹ Keio University, Tokyo, Japan.
¹² St. Marianna University, Kanagawa, Japan.
¹³ Nagoya University, Nagoya, Japan.

PMID: 27099135
PMCID: PMC4891375
DOI: 10.1007/s10157-015-1218-8

Review

Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014

Yoshihiro Arimura et al. Clin Exp Nephrol. 2016 Jun.

. 2016 Jun;20(3):322-41.

doi: 10.1007/s10157-015-1218-8.

Authors

Affiliations

¹ Kyorin University, Tokyo, Japan. arimuray@ks.kyorin-u.ac.jp.
² Kitano Hospital, Osaka, Japan.
³ Miyazaki University, Miyazaki, Japan.
⁴ Fujita Health University, Aichi, Japan.
⁵ Kyorin University, Tokyo, Japan.
⁶ Tsukuba University, Ibaraki, Japan.
⁷ Kyoto University, Kyoto, Japan.
⁸ Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
⁹ Tokyo Women's Medical University, Tokyo, Japan.
¹⁰ Kanazawa Medical Center, Ishikawa, Japan.
¹¹ Keio University, Tokyo, Japan.
¹² St. Marianna University, Kanagawa, Japan.
¹³ Nagoya University, Nagoya, Japan.

PMID: 27099135
PMCID: PMC4891375
DOI: 10.1007/s10157-015-1218-8

No abstract available

PubMed Disclaimer

Figures

Fig. 1 — Fig. 1
Treatment algorithm for ANCA-positive RPGN and CQs (changed from reference: the RPGN clinical practice guide 2011 by the Progressive Renal Disease Research, from the Ministry of Health, Labour and Welfare of Japan). Asterisk For older patients over 70 years, lower-grade treatment may be considered including the regimen without pulse methylprednisolone. Asterisk At the specialized hospital, higher-grade treatment may be considered under careful management irrespective of age and clinical grades. Please see other treatments (CQ 13 for Rituximab therapy, CQ 14 for Plasma exchange therapy, CQ15 for anti-coagulation and antiplatelet therapy, and CQ20 for co-trimoxazole therapy). RPGN rapidly progressive glomerulonephritis, PSL prednisolone, OCS oral corticosteroid

Fig. 2 — Fig. 2
Differential diagnosis of RPGN and treatment options. The algorithm for diagnosis and treatment with corresponding CQs are shown in this figure. OCS oral corticosteroid, IS immunosuppressant, PEx plasma exchange, RTX rituximab, IVIG intravenous immunoglobulin

See this image and copyright information in PMC

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov